| Dr Shanna Jean Brown, MD | |
|
1309 E Ridge Rd Ste 1, Mcallen, TX 78503-1518 | |
| (956) 631-8875 | |
| (956) 683-1502 |
| Full Name | Dr Shanna Jean Brown |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 16 Years |
| Location | 1309 E Ridge Rd Ste 1, Mcallen, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467613513 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | P2961 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fort Duncan Medical Center | Eagle pass, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ophthalmic Consultants Of Texas P.a. | 7416055686 | 11 |
News Archive
Patients with coronary heart disease who practiced the stress-reducing Transcendental Meditation® technique had nearly 50 percent lower rates of heart attack, stroke, and death compared to nonmeditating controls, according to the results of a first-ever study presented during the annual meeting of the American Heart Association in Orlando, Fla., on Nov.16, 2009.
DynaVox Inc., a leading provider of software, devices and content to assist people in overcoming their speech, language or learning disabilities, announced today that its initial public offering of 9,375,000 shares of its Class A common stock has been priced at $15.00 per share. The shares are expected to begin trading tomorrow, April 22, 2010, on the NASDAQ Global Select Market under the ticker symbol "DVOX."
Phase 2 trial results published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, suggests the potential for Glycerol Phenylbutyrate (GPB) to reduce hepatic encephalopathy episodes in patients with cirrhosis, with a safety profile similar to placebo.
Washing with soap and water is second nature for many. But in many other places around the world, handwashing with soap is rare.
› Verified 2 days ago
| Entity Name | Valley Retina Institute P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225139942 PECOS PAC ID: 7113903659 Enrollment ID: O20040625000871 |
News Archive
Patients with coronary heart disease who practiced the stress-reducing Transcendental Meditation® technique had nearly 50 percent lower rates of heart attack, stroke, and death compared to nonmeditating controls, according to the results of a first-ever study presented during the annual meeting of the American Heart Association in Orlando, Fla., on Nov.16, 2009.
DynaVox Inc., a leading provider of software, devices and content to assist people in overcoming their speech, language or learning disabilities, announced today that its initial public offering of 9,375,000 shares of its Class A common stock has been priced at $15.00 per share. The shares are expected to begin trading tomorrow, April 22, 2010, on the NASDAQ Global Select Market under the ticker symbol "DVOX."
Phase 2 trial results published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, suggests the potential for Glycerol Phenylbutyrate (GPB) to reduce hepatic encephalopathy episodes in patients with cirrhosis, with a safety profile similar to placebo.
Washing with soap and water is second nature for many. But in many other places around the world, handwashing with soap is rare.
› Verified 2 days ago
| Entity Name | Ophthalmic Consultants Of Texas P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063513794 PECOS PAC ID: 7416055686 Enrollment ID: O20070612000372 |
News Archive
Patients with coronary heart disease who practiced the stress-reducing Transcendental Meditation® technique had nearly 50 percent lower rates of heart attack, stroke, and death compared to nonmeditating controls, according to the results of a first-ever study presented during the annual meeting of the American Heart Association in Orlando, Fla., on Nov.16, 2009.
DynaVox Inc., a leading provider of software, devices and content to assist people in overcoming their speech, language or learning disabilities, announced today that its initial public offering of 9,375,000 shares of its Class A common stock has been priced at $15.00 per share. The shares are expected to begin trading tomorrow, April 22, 2010, on the NASDAQ Global Select Market under the ticker symbol "DVOX."
Phase 2 trial results published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, suggests the potential for Glycerol Phenylbutyrate (GPB) to reduce hepatic encephalopathy episodes in patients with cirrhosis, with a safety profile similar to placebo.
Washing with soap and water is second nature for many. But in many other places around the world, handwashing with soap is rare.
› Verified 2 days ago
| Entity Name | Visione 360 Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184866808 PECOS PAC ID: 8123175650 Enrollment ID: O20090420000499 |
News Archive
Patients with coronary heart disease who practiced the stress-reducing Transcendental Meditation® technique had nearly 50 percent lower rates of heart attack, stroke, and death compared to nonmeditating controls, according to the results of a first-ever study presented during the annual meeting of the American Heart Association in Orlando, Fla., on Nov.16, 2009.
DynaVox Inc., a leading provider of software, devices and content to assist people in overcoming their speech, language or learning disabilities, announced today that its initial public offering of 9,375,000 shares of its Class A common stock has been priced at $15.00 per share. The shares are expected to begin trading tomorrow, April 22, 2010, on the NASDAQ Global Select Market under the ticker symbol "DVOX."
Phase 2 trial results published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, suggests the potential for Glycerol Phenylbutyrate (GPB) to reduce hepatic encephalopathy episodes in patients with cirrhosis, with a safety profile similar to placebo.
Washing with soap and water is second nature for many. But in many other places around the world, handwashing with soap is rare.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shanna Jean Brown, MD Po Box 4830, Edinburg, TX 78540-4830 Ph: (956) 631-8875 | Dr Shanna Jean Brown, MD 1309 E Ridge Rd Ste 1, Mcallen, TX 78503-1518 Ph: (956) 631-8875 |
News Archive
Patients with coronary heart disease who practiced the stress-reducing Transcendental Meditation® technique had nearly 50 percent lower rates of heart attack, stroke, and death compared to nonmeditating controls, according to the results of a first-ever study presented during the annual meeting of the American Heart Association in Orlando, Fla., on Nov.16, 2009.
DynaVox Inc., a leading provider of software, devices and content to assist people in overcoming their speech, language or learning disabilities, announced today that its initial public offering of 9,375,000 shares of its Class A common stock has been priced at $15.00 per share. The shares are expected to begin trading tomorrow, April 22, 2010, on the NASDAQ Global Select Market under the ticker symbol "DVOX."
Phase 2 trial results published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, suggests the potential for Glycerol Phenylbutyrate (GPB) to reduce hepatic encephalopathy episodes in patients with cirrhosis, with a safety profile similar to placebo.
Washing with soap and water is second nature for many. But in many other places around the world, handwashing with soap is rare.
› Verified 2 days ago
Vimal Sarup, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1309 E Ridge Rd Ste 1, Mcallen, TX 78503 Phone: 956-631-8875 Fax: 956-683-1502 | |
Dr. Rachel Ann Gelman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5201 N G St, Mcallen, TX 78504 Phone: 956-305-5795 Fax: 956-618-4639 | |
Dr. Raul Adrian Pena, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Ridge Rd Ste 10, Mcallen, TX 78503 Phone: 956-661-8733 Fax: 956-661-8724 | |
Dr. Melissa Ixcamey, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1309 E Ridge Rd Ste 1, Mcallen, TX 78503 Phone: 956-844-6440 | |
Cooper M Clark, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1309 E Ridge Rd, Suite 1, Mcallen, TX 78503 Phone: 956-631-8875 Fax: 956-682-6280 | |
Dr. Wade Alan Graham, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Ridge Rd Ste 3, Mcallen, TX 78503 Phone: 956-429-4900 Fax: 956-429-4901 | |
Dr. Nehal Rashmikant Patel, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1309 East Ridge Road, Suite 1, Mcallen, TX 78503 Phone: 956-631-8875 Fax: 956-631-9134 |